PA
EXAS

Pinnacle Associates’s Exact Sciences EXAS Stock Holding History

Pinnacle Associates’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,835
Closed -$288K – 965
2025
Q4 		$288K Buy
+2,835
New +$228K ﹤0.01% 801

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Pinnacle Associates's EXAS Position: Q1 2026 in Review

Pinnacle Associates sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,835 shares — an estimated $288K sold.

Pinnacle Associates first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $288K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Pinnacle Associates reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Pinnacle Associates sold 2,835 Exact Sciences shares in Q1 2026, an estimated $288K.
  • Pinnacle Associates first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Pinnacle Associates's Exact Sciences position peaked at $288K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.